DHCNI
DHCNI
Diversified Healthcare Trust -Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $366.47M ▼ | $-45.18M ▼ | $-43.27M ▼ | -11.81% ▼ | $-0.18 ▼ | $57.29M ▼ |
| Q4-2025 | $379.57M ▼ | $-40.37M ▼ | $-21.22M ▲ | -5.59% ▲ | $-0.09 ▲ | $136.27M ▲ |
| Q3-2025 | $388.71M ▲ | $78.11M ▲ | $-164.04M ▼ | -42.2% ▼ | $-0.68 ▼ | $-53.77M ▼ |
| Q2-2025 | $382.71M ▼ | $77.44M ▲ | $-91.64M ▼ | -23.94% ▼ | $-0.38 ▼ | $23.34M ▼ |
| Q1-2025 | $386.86M | $9M | $-8.99M | -2.32% | $-0.04 | $63.54M |
What's going well?
Interest costs are down sharply, which helps reduce financial pressure. Operating losses narrowed, showing some improvement in core operations.
What's concerning?
Revenue is falling, and the company is still losing money on every sale. Large 'other' expenses and negative gross margins show the business model is under real stress.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $121.77M ▼ | $4.27B ▼ | $2.65B ▼ | $1.62B ▼ |
| Q4-2025 | $121.8M ▼ | $4.36B ▼ | $2.7B ▼ | $1.67B ▼ |
| Q3-2025 | $201.37M ▲ | $4.68B ▼ | $3B ▲ | $1.69B ▼ |
| Q2-2025 | $141.77M ▼ | $4.76B ▼ | $2.9B ▼ | $1.85B ▼ |
| Q1-2025 | $302.58M | $5B | $3.05B | $1.95B |
What's financially strong about this company?
The company has very strong liquidity, with far more cash than near-term bills. Debt is mostly long-term, giving them breathing room. No goodwill or hidden liabilities means the balance sheet is straightforward.
What are the financial risks or weaknesses?
Most assets are tied up in investments, not cash or physical assets. Retained losses are large, showing a history of unprofitability. Book value and total assets are slowly declining.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $-43.27M ▼ | $8.34M ▲ | $13.58M ▼ | $-3.87M ▲ | $18.05M ▲ | $8.34M ▲ |
| Q4-2025 | $-21.22M ▲ | $-20.11M ▲ | $207.42M ▲ | $-275.13M ▼ | $-87.82M ▼ | $-20.11M ▲ |
| Q3-2025 | $-164.04M ▼ | $-49.28M ▼ | $6.12M ▲ | $104.21M ▲ | $61.04M ▲ | $-49.28M ▼ |
| Q2-2025 | $-91.64M ▼ | $53.02M ▲ | $-21.05M ▼ | $-190.04M ▼ | $-158.07M ▼ | $53.02M ▲ |
| Q1-2025 | $-8.99M | $-3.24M | $291.09M | $-131.05M | $156.8M | $-3.24M |
What's strong about this company's cash flow?
The company swung from burning cash to generating $8.3 million in free cash flow, despite reporting a large accounting loss. Cash on hand increased and the business isn't relying on outside funding.
What are the cash flow concerns?
Net losses are growing and working capital swings are unpredictable. The improvement may not be sustainable if working capital turns negative again.
Revenue by Products
| Product | Q1-2025 | Q3-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|
Rental Income | $60.00M ▲ | $60.00M ▲ | $110.00M ▲ | $50.00M ▼ |
Resident Fees And Services | $330.00M ▲ | $330.00M ▲ | $650.00M ▲ | $320.00M ▼ |
Q1 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Diversified Healthcare Trust -'s financial evolution and strategic trajectory over the past five years.
The company combines a sizable, tangible healthcare real estate portfolio with very strong short-term liquidity and solid reported equity. Its revenue base and positive EBITDA show that the assets do generate underlying value, especially before financing costs. Diversification across medical office, life science, and senior housing, together with the expertise of The RMR Group and a shift to multiple senior housing operators, provides strategic flexibility and potential for operational improvement.
Key risks center on weak profitability, negative cash generation, and substantial leverage. Negative gross profit and a deep net loss signal that the economic model, as currently configured, is not sustainable without improvement. High debt levels and significant accumulated losses compound the risk, particularly in an environment where interest costs may stay elevated. Operational complexity in senior housing, competitive pressures across healthcare real estate, and limited reinvestment in properties also add to the uncertainty.
The outlook is mixed. On one hand, demographic tailwinds—especially an aging population and steady demand for healthcare services—support long-term need for the types of properties DHCNI owns. Strategic actions like re-tenanting senior housing, capital recycling, and deleveraging could gradually strengthen financial performance. On the other hand, the current starting point involves ongoing losses, negative free cash flow, and meaningful debt. Future results will depend heavily on how effectively management can improve property-level economics, manage interest and refinancing risk, and balance short-term liquidity with the need to invest in and refresh the portfolio.
About Diversified Healthcare Trust -
http://www.dhcreit.comDiversified Healthcare Trust operates as a real estate investment trust (REIT) primarily focused on acquiring and managing properties within the healthcare sector. Its portfolio includes senior living facilities, medical office buildings, and various wellness centers.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $366.47M ▼ | $-45.18M ▼ | $-43.27M ▼ | -11.81% ▼ | $-0.18 ▼ | $57.29M ▼ |
| Q4-2025 | $379.57M ▼ | $-40.37M ▼ | $-21.22M ▲ | -5.59% ▲ | $-0.09 ▲ | $136.27M ▲ |
| Q3-2025 | $388.71M ▲ | $78.11M ▲ | $-164.04M ▼ | -42.2% ▼ | $-0.68 ▼ | $-53.77M ▼ |
| Q2-2025 | $382.71M ▼ | $77.44M ▲ | $-91.64M ▼ | -23.94% ▼ | $-0.38 ▼ | $23.34M ▼ |
| Q1-2025 | $386.86M | $9M | $-8.99M | -2.32% | $-0.04 | $63.54M |
What's going well?
Interest costs are down sharply, which helps reduce financial pressure. Operating losses narrowed, showing some improvement in core operations.
What's concerning?
Revenue is falling, and the company is still losing money on every sale. Large 'other' expenses and negative gross margins show the business model is under real stress.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $121.77M ▼ | $4.27B ▼ | $2.65B ▼ | $1.62B ▼ |
| Q4-2025 | $121.8M ▼ | $4.36B ▼ | $2.7B ▼ | $1.67B ▼ |
| Q3-2025 | $201.37M ▲ | $4.68B ▼ | $3B ▲ | $1.69B ▼ |
| Q2-2025 | $141.77M ▼ | $4.76B ▼ | $2.9B ▼ | $1.85B ▼ |
| Q1-2025 | $302.58M | $5B | $3.05B | $1.95B |
What's financially strong about this company?
The company has very strong liquidity, with far more cash than near-term bills. Debt is mostly long-term, giving them breathing room. No goodwill or hidden liabilities means the balance sheet is straightforward.
What are the financial risks or weaknesses?
Most assets are tied up in investments, not cash or physical assets. Retained losses are large, showing a history of unprofitability. Book value and total assets are slowly declining.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $-43.27M ▼ | $8.34M ▲ | $13.58M ▼ | $-3.87M ▲ | $18.05M ▲ | $8.34M ▲ |
| Q4-2025 | $-21.22M ▲ | $-20.11M ▲ | $207.42M ▲ | $-275.13M ▼ | $-87.82M ▼ | $-20.11M ▲ |
| Q3-2025 | $-164.04M ▼ | $-49.28M ▼ | $6.12M ▲ | $104.21M ▲ | $61.04M ▲ | $-49.28M ▼ |
| Q2-2025 | $-91.64M ▼ | $53.02M ▲ | $-21.05M ▼ | $-190.04M ▼ | $-158.07M ▼ | $53.02M ▲ |
| Q1-2025 | $-8.99M | $-3.24M | $291.09M | $-131.05M | $156.8M | $-3.24M |
What's strong about this company's cash flow?
The company swung from burning cash to generating $8.3 million in free cash flow, despite reporting a large accounting loss. Cash on hand increased and the business isn't relying on outside funding.
What are the cash flow concerns?
Net losses are growing and working capital swings are unpredictable. The improvement may not be sustainable if working capital turns negative again.
Revenue by Products
| Product | Q1-2025 | Q3-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|
Rental Income | $60.00M ▲ | $60.00M ▲ | $110.00M ▲ | $50.00M ▼ |
Resident Fees And Services | $330.00M ▲ | $330.00M ▲ | $650.00M ▲ | $320.00M ▼ |
Q1 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Diversified Healthcare Trust -'s financial evolution and strategic trajectory over the past five years.
The company combines a sizable, tangible healthcare real estate portfolio with very strong short-term liquidity and solid reported equity. Its revenue base and positive EBITDA show that the assets do generate underlying value, especially before financing costs. Diversification across medical office, life science, and senior housing, together with the expertise of The RMR Group and a shift to multiple senior housing operators, provides strategic flexibility and potential for operational improvement.
Key risks center on weak profitability, negative cash generation, and substantial leverage. Negative gross profit and a deep net loss signal that the economic model, as currently configured, is not sustainable without improvement. High debt levels and significant accumulated losses compound the risk, particularly in an environment where interest costs may stay elevated. Operational complexity in senior housing, competitive pressures across healthcare real estate, and limited reinvestment in properties also add to the uncertainty.
The outlook is mixed. On one hand, demographic tailwinds—especially an aging population and steady demand for healthcare services—support long-term need for the types of properties DHCNI owns. Strategic actions like re-tenanting senior housing, capital recycling, and deleveraging could gradually strengthen financial performance. On the other hand, the current starting point involves ongoing losses, negative free cash flow, and meaningful debt. Future results will depend heavily on how effectively management can improve property-level economics, manage interest and refinancing risk, and balance short-term liquidity with the need to invest in and refresh the portfolio.

CEO
Christopher J. Bilotto
Compensation Summary
(Year )
ETFs Holding This Stock
Summary
Showing Top 3 of 7
Ratings Snapshot
Rating : D+

